Healthy Skepticism Library item: 6438

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

O'Sullivan DP.
Bromocriptine and drug information.
Lancet 1994 Jan 29; 343:(8892):297

Abstract:

The United States and United Kingdom drug compendia are in fact in agreement in relation to the occurrence of headache in patients receiving bromocriptine therapy. Sandoz makes every effort to ensure that the prescribing information provided to clinicians is consistent on an international basis.

Keywords:
*letter to the editor/United Kingdom/Sandoz/Parlodel/industry perspective/commercial compendia/quality of information/safety & risk information/developed countries/EVALUATION OF PROMOTION: COMMERCIAL DRUG COMPENDIA/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES Bromocriptine/adverse effects* Drug Information Services/standards* Female Great Britain Headache/chemically induced* Humans Prescriptions, Drug United States